AcquisitionsJun 29, 2026, 04:47 PM
XTL Biopharmaceuticals Shareholders Approve Psyga Bio Acquisition
AI Summary
XTL Biopharmaceuticals Ltd. announced the results of its Extraordinary General Meeting of Shareholders, where all proposals were approved. Key approvals include the acquisition of 80-100% of Psyga Bio Ltd., a private placement of up to US$1,500,000, and an increase in the company's authorized share capital by 2,900,000,000 shares. Additionally, BARZILY & CO. C.P.A was appointed as the independent registered public accounting firm for 2025.
Key Highlights
- Shareholders approved the acquisition of 80-100% of Psyga Bio Ltd.
- Approved a private placement of up to US$1,500,000 from Mr. Alexander Rabinovitch and/or other investors.
- Authorized share capital increased by 2,900,000,000 shares, totaling 5,800,000,000 ordinary shares.
- BARZILY & CO. C.P.A appointed as independent registered public accounting firm for the year ending December 31, 2025.
Price Impact
More from XTLB